期刊文献+

醛酮还原酶的研究进展 被引量:4

The Research Progress of Aldo Keto Reductase
原文传递
导出
摘要 文章综述了醛酮还原酶的研究进展。醛酮还原酶(AKRs)是氧化还原酶超家族成员之一,目前已知有16个家族,超过190个家族成员,AKRs成员均属于单体胞质蛋白,以还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH)作为其辅酶,将醛酮类化合物还原成相应的醇类。近年来相关研究证实AKRs与多种疾病密切相关,因此,了解醛酮还原酶与多种疾病的关系意义重大。 Aldo keto reductase (AKRs) is an oxidoreductase supeffamily. As far as we know,it embraces 16 families and more than190 family members. AKRs members are single cytoplasmic proteins ,including nicotinamide adenine dinueleotide phosphate (NADPH)as its eoenzyme;aldehyde and ketone compounds will be reduced to the corresponding alcohols. Recent studies have confirmed thatAKRs are closely related with many diseases. The role of AKRs in various diseases has been reviewed.
作者 舒楠 陈子珺
出处 《药物生物技术》 CAS 2017年第2期175-179,共5页 Pharmaceutical Biotechnology
基金 国家自然科学基金(No.81403146)
关键词 醛酮还原酶 疾病 研究进展 综述 Aldo keto reduetase, Diseases, Research progress, Reviews
  • 相关文献

参考文献6

二级参考文献134

  • 1Jin G Z,Li Y,Cong W M,Yu H,Dong H,Shu H,et al. ITRAQ- 2DLC-ESI-MS/MS based identification of a new set of immunohis- tochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma [ J ]. Prot eome Res, 2011,10 : 3418 3428. htt p : / / pubs. acs. org/ doi/ suppl/10. 1021/pr200482t / suppl _file/ pr200482t_si_O01, pd f.
  • 2LuXY,XiT,LauWY,DongH,ZhuZ,ShenF,etal. Hepato- cellular carcinoma expressing cholangiocyte phenotype is a no vel subtype with highly aggressive behavior [J].Ann Surg On- eol,2011,18:2210-2217.
  • 3Penning T M, Drury J E. Human aldo-keto reductases: func- tion,gene regulation,and single nueleotide polymorphisms[J]. Arch Bioehem Biophys, 2007,464 : 241-250.
  • 4Zeindl-Eberhart E,Klugbauer S, Dimitrijevic N,Jungblut P R, Lamer S, Rabes H M. Proteome anaylsis of rat hepatomas:car- cinogen-dependent tumor-associated protein variants[J]. Elec- trophoresis, 2001,22 : 3009-3018.
  • 5Woenckhaus M, Klein-Hitpass L,Grepmeier U, Merk J, PIeifer M,Wild P,et al. Smoking and cancer related gene expression in bronchial epithelium and non-small-cell lung cancers [J]. J Pathol,2006,210: 192-204.
  • 6Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A,Shibahara J, et al. Overexpression of the aldokketo reductase family protein AKR1B10 is highly correlated with smokers' non-smallcell lung carcinomas[J].Clin Cancer Res, 2005, 11: 1776-1785.
  • 7Yoshitake H, Takahashi M, lshikawa H, Nojima M, lwanari H, Watanabe A, et al. Aldo-keto reductase family 1, member B10 in uterine carcinomas:a potential risk factor of recurrence after surgicaltherapy in cervical cancer[J]. Int J Gynecol Cancer, 2007,17 : 1300-1306.
  • 8Alary J, Gueraud F, Cravedi JP. Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways [J ]. Mol Aspects Med, 2003,24 (4-5):177-187.
  • 9VanderVeen LA,Hashim MF,Nechev LV,et al. Evaluation of the mutagenic potential of the principal DNA adduct of acrolein [J ]. J Biol Chem, 2001,276( 12 ) : 9066-9070.
  • 10Singh M,Nam DT,Arseneault M,et al. Role of by-products of lipid oxidation in Alzheimer' s disease brain:a focus on acrolein [J]. J Alzheimers Dis, 2010,21 ( 3 ) : 741-756.

共引文献12

同被引文献48

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部